TWM392663U - Fabric for promoting tissue growth - Google Patents

Fabric for promoting tissue growth Download PDF

Info

Publication number
TWM392663U
TWM392663U TW99212319U TW99212319U TWM392663U TW M392663 U TWM392663 U TW M392663U TW 99212319 U TW99212319 U TW 99212319U TW 99212319 U TW99212319 U TW 99212319U TW M392663 U TWM392663 U TW M392663U
Authority
TW
Taiwan
Prior art keywords
fabric
tissue growth
wires
wire
materials
Prior art date
Application number
TW99212319U
Other languages
Chinese (zh)
Inventor
shu-hui Yu
Fu-Long Mi
Yu-Fan Lin
Hao-Ying Xie
Original Assignee
Univ Vanung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanung filed Critical Univ Vanung
Priority to TW99212319U priority Critical patent/TWM392663U/en
Publication of TWM392663U publication Critical patent/TWM392663U/en

Links

Description

五、新型說明: 【新型所屬之技術領域】 本新型是有關於-種織物,特別是指一種可促進組織 生長的織物。 【先前技術】 當身體組織,例如皮膚、各種肌肉或骨路等,受到傷 害時,通常身體會自行啟動修復機制,一方面藉由從傷口 周邊慢慢增生出新的細胞與組織以包覆受傷部位,另一方 面,配合新陳代謝的機制’將老舊的受傷細胞與組織吞嗟 ’進而達到傷口修復的效果。 如果傷口不能癒合,就容易造成細菌侵入感染,而引 起併發症’甚至危及生命。其中,傷口的種類、大小、以 及傷者的營養狀況、年紀、是否患有其他疾病及使用藥物 等諸多因素,都會影響傷口癒合的過程及時間。為了加速 傷口癒合,減低感染發生的機率,癒合過程中通常會在傷 口處以適當的敷料加以遮蓋。 現有的敷料產品,從隨手可得,諸如修復面膜、ok端 、紗布、消毒繃帶之類的簡易型修復產品,到外科手術所 使用的貼料、骨支架,通常都是在織物上塗佈具有醫療效 果之藥物。而織物主要是由具有輔助固定、透氣、抗菌效 果的材質所構成,通常只能提供覆蓋傷口,及減少外部细 菌外染的功能。至於傷口修復、組織生長等效果主要還 是得依靠身體本身的修復機制。 因此’如何提升織物的功能性,使其不但具有現有醫 3 M392663 __㈣定與Μ的功效,還能進—步提供促進組織 生長及加速傷口癒合的魏,成為目冑臨床醫學與美容醫 學上有關修復研究㈣要課題,也是—項值得深入研究的 關鍵技術。 【新型内容】 因此’本新型之目#,即在提供一種兼具有固定包覆 及加速傷Π修復癒合功能的可促進組織生長的織物。 於是,本新型可促進組織生長的織物,包含一第一纖 維層’及-結合在該第一纖維層的第二纖維層。 該第一纖維層包括多數條沿—第一方向相舖疊結合成 片的第-線材’且該等第—線材是由—選自下列群組令的 纖維所1成·#'絲、麻、人造纖維,及所述材料的組合 0 疋箱兮在該第 沿-第二方向舖疊在該等第_線#上的第二線材,該等 :線材分別是由—生物高分子㈣抽製形成的生物纖維; 氣成,該生物高分子膠體包含一幾丁聚聽衍生物。 本新型的有益效果在於:藉由該等第一、第二線… 二成該第一、.第二纖維層,再進一步結合成片狀她 :的設計,使該織物仍具有辅助固定與透氣的使用功能 =能透過該第:纖維㈣第二線材提供促進細胞活化與力 1且:生長的效果,使本新型具有可進一步製成臨㈣ 、美谷醫學與細胞培養之應用產品的實用價值。 進步地,本新型還提供另—種型式的可促進組織生 4 長的織物,包含多數條第—線材,及多數條與該等第 材相交織結合成片狀布體結構的第二線材。 該等苐一線材是沿一第一 列群組中的纖維所製成:棉、 材料的組合。 方向設置,且是由一選自下 絲、麻、人造纖維,及所述 該等第二線材是沿一不平行於該第一方向的第二方向 與該等第-線材相交織形成片狀布體結構,且該等第二線 材分別是由-生物高分子膠體抽製形成的生物纖維所& ,該生物高分子膠體包含一幾丁聚醣衍生物。 本新型的有益效果在於:藉由該等第一'第二線材相 交織形成的片狀布體結構,使該織物仍具有辅助固定與透 氣的使用功能’並料過該等第二線材產生促進細胞活化 與加速組織生長的效果,藉此,同樣使本新型具有可進一 步製成臨床醫學、美容醫學與細胞培養之應用產品的實用 價值。 【實施方式】 有關本新型之前述及其他技術内容、特點與功效,在 以下配合參考圖式之二個較佳實施例的詳細說明中,將可 清楚的呈現。 參閱圖1與圖2’本新型可促進組織生長的織物2的第 -較佳實施例包含-第-纖維m 一結合在-該第_纖維 層上的第二纖維層4。 該第一纖維層3包括多數條沿一第一方向相舖疊結合 成片的第-線材31,且該等第一線材31是由一選自下列群 M392663 人造纖維,及所述材料 組中的纖維所製成:棉、絲、麻 的組合。 =第二纖維層4是結合在該第-纖維層3上,包括多 數條沿一與該第一方向相平行的二 31 f- ^ ^ —方向舖疊在該等第一 線材上的第二線材41,該等第二線材 物高分子膠體抽製形成的生物纖: 子谬體包含-幾丁聚膽衍生物。 4成,该生物"分 在:實施例中,該等第一線材31、第二線材Ο是透過 現有不織布的製造技術製成片體型式的布體結構。其中, t成該第二線材41的生物纖維411較佳是製成具有異型多 面Γ構的中空纖維,此種纖維結構設計有助於提供細 匕争留空間與組織生長所需之養分傳輸,而能增進該織物2 的使用效果。在本實施例中,該幾丁聚聽衍生物是幾丁聚 酿,聚麵胺酸之離子聚合物,因此,該第二線材Μ的生物 纖維411是利用幾丁聚醋與聚麩胺酸之混合溶液,經由 抽絲製程製成具有異型多摺斷面的中空、纖維。 ^ 八中,幾丁聚醣(Chitosan)是近年來生物科技的新素材 ,其具有良好的生物相容性、良好抗菌性 '生物可分解性 及無毒性等,而且具有製造簡單、價格便宜、生產原料不 虞置之等優點。在酸性環境下,幾丁聚醣的氨基能夠被質 子化’進而帶有正電荷。所以幾丁聚醣是一個可帶有正電 的天然高分子。再者,由於幾丁聚醣結構中的氨基具有反 Μ ’因此幾丁聚醣得以交聯劑方式進行反應再進一步成 型為特定型式的結構體,藉此,能將其製成特定結構的產 M392663 品進而能增加其應用範圍與實用價值。 聚麩胺酸(7 -PGA)是目前相當受矚目的一種天然生物 可分解材料,其存在於納豆食品中之黏絲,已有千年以上 的歷史,其材料本身安全又無毒性,能與生物體完全相容 且具有生物可分解性。7 -PGA經生物分解後再成為麩胺酸 ,仍是重要的營養成分。由於g-PGA含有很多COOH基且 能呈現多種結.構功能形態(Conformational states),而具備化 學與生物學上的多功能特性。例如,g-PGA在中性溶液中 可與多種重金屬離子螯合(Chelating)並產生沉殿,g-PGA還 具有能與多種具生理功能蛋白質強烈結合(binding)的能力, 此外,g-PGA也具有可與鈣離子和鎂離子結合成離子配位 錯鹽離子結構(Coordinated ionic complex)的功能。因此,g-PGA具良好的保健功能。再者,g-PGA特強的親水保水能 力和形成配位錯鹽離子的功能,以及線性的結構等,使其 具有能有效地促進鈣吸收、骨成長和其他保健生理的功效 ,極具保健和營養功能等價值。 膠體抽絲又稱為化學纖維成形,乃是製造化學纖維的 一道工序。其大致作法為將高分子材料製成膠體溶液或融 化成熔體後,由喷絲頭細孔壓出行程製成化學纖維。 藉由結合具有高抗菌性、高生物相容性、生物可分解 性、以及無毒性的幾丁聚醣,與具有高生物相容性、高保 濕力、與蛋白質、鈣離子、鎂離子之結合能力等優點的聚 麩胺酸,並經由抽絲工序將幾丁聚醣與聚麩胺酸的離子聚 合物膠體溶液製成具有多褶斷面的中空纖維作為該等生物 7 纖維川,並進-步將該等生物纖維4ii分別捻製成該等第 一線材41 ’再與該等第—線材η相結合形成片體型式的織 物將可利用該等第二線材41的材質特性達到活化細胞 與促進組織生長的效果,且#將該織# 2敷布在傷口部位 恰,此有效的提升該部位的修復效果。 藉此1用該等第二線材41㈣質成分所產生的功效 ,及該等第一、第二線材31、41能透過現有不織布製程結 合成布體結構的特性,使該可促進組織生長的織物2,能進 一步被製成一選自下列群組中的產品:骨組織支架的包覆 材料、臨床醫學之敷料、美容醫學之身體修復膜片、美容 醫學之面膜及細胞培養基材。而具有廣泛的應用範圍。 參閱圖3與圖4,為本新型可促進組織生長的織物5的 一第二較佳實施例,該織物5包含多數條第一線材51,及 多數條與該等第一線材5 1相交織結合成片狀布體結構的第 二線材52。 該等第一線材51是沿一第一方向X設置,且是由一選 自下列群組中的纖維所製成:棉、絲、麻、人造纖維,及 所述材料的組合。 該等第二線材52是沿一不平行於該第一方向X的第二 方向Y與該等第一線材5 1相交織形成片狀布體結構,且該 等第二線材52分別是由一生物高分子膠體抽製形成的生物 纖維521所製成,該生物高分子膠體包含一幾丁聚醣衍生 物。在本實施例中,該幾丁聚醣衍生物同樣是幾丁聚醣與 聚麩胺酸之離子聚合物。且形成該線材52的生物纖維也是 I成具有異型斷面結構的中空纖維型式。在此是採用現有 的、'二緯線紡織技術來製成該織物 5。且該等第一、第二線材 51、52相結合的織法不受限。 在本實施例所採用的經緯紡織製程,主要是先將選自 、'V、'棘 '人造纖維或其他現有材質的纖維所捻製成的 5玄等第_ ^41.» ~ . 、咏何51设置於一紡織裝置(圖未示)的經度(或緯度) 製:再將4 丁聚醣之衍生物經過膠體抽絲技術所進一步 侍的該等第二線材52設置於該紡織裝置的緯度(或經度) 〜向接下來,以該等第一線材51與該等第二線材52進 一、令式的紡織工序,就能製得本實施例的可促進組織生 長的織物5。 以交織方式製成的該織物2,同樣可經由該等第二線材 的材貝特性產生活化細胞及促進組織生長與修復的功能 同樣能進一步製成—選自下列群組中的產品:骨組織 支架的包覆材料、臨床醫學之敷料、美容醫學之身體修復 膜片美谷醫學之面膜及細胞培養基材。 ,需要補充說明的是,用於製成該第一、第二較佳實施 例中的第二線材41、52的生物纖維4ιι、52ι的一具體製造 將的幾丁聚醣lg加至10_純水中,利用醋酸調 整至pH約為4,並利用磁石授拌機撥拌溶解^取%聚麵 胺酸叫加至_ml純水中,並利用磁石撥拌機授掉溶解 ’及將幾T聚醣水溶液分別滴人㈣胺酸水溶液中,使兩 種溶液混合後形成介面反應,再將其抽成纖維,接著,婉 M392663 過酒精固化、烘箱烘乾、繞曲等工序之後,就能得到幾丁 聚醣-聚麩胺酸之離子交連纖維。參閲圖3與圖4,該等纖 維即被用作前述第一、第二較佳實施例中的生物纖維4丨工、 521,經由捻製技術,可使該等生物纖維411、521集結成束 ’分別製成該等第二線材41 ' 52。 歸納上述,本新型可促進組織生長的織物2、5,可獲 致下述的功效及優點’故能達到本新型的目的: —、根據該第一、第二較佳實施例,以該等生物纖維 411、521形成的第二線材41、52不僅可藉由幾丁聚醣與聚 麩胺酸來提供細胞培養的適當環境,幾丁聚醣-聚麵胺酸的 離子交連纖維所具有的中空與異型縐褶斷面結構,更可提 供細胞停留的空間與組織生長時所需之養分傳輸。據此說 明該第一、第二較佳實施例之可促進組織生長的織物2、5 可以有效地促進細胞與組織的生長。因而該可促進組織生 長的織物2、5可應用於臨床醫學的傷口敷材、骨材培養基 材、細胞培養基材、骨支架包覆敷材、或其他外科方面與 細胞修復、生長相關之應用,以及美容醫學方面的修復面 膜、或其他身體部位之修復膜片,例如手膜、腳膜等。 二、由於該可促進組織生長的織物2、5的第—線材Μ 、51與第二線材41、52都是由可被分解的成分所製成,因 此,以該織物2、5進一步製成的產品使用後要不會有無法 分解而容易成為環境負擔的問題,因此,該織物2、$兼具 有符合環保需求的功效。 惟以上所述者,僅為本新型之較佳實施例而已,當不 10 M392663 月b以此限定本新型實施之範園,即大凡依本新型申請專利 範圍及新型說明内容所作之簡單的等效變化與㈣,皆仍 屬本新型專利涵蓋之範圍内。 【圖式簡單說明】 圖!是一局部立體示意圖,說明本新型可促進組織生 長的織物的一第一較佳實施例;V. New description: [New technical field] The present invention relates to a kind of fabric, especially a fabric which can promote tissue growth. [Prior Art] When body tissues, such as skin, various muscles, or bone paths, are injured, the body usually initiates a repair mechanism by itself, and on the other hand, by infusing new cells and tissues from the periphery of the wound to wrap the wounds. The site, on the other hand, cooperates with the metabolic mechanism of 'swallowing old injured cells and tissues' to achieve wound healing. If the wound does not heal, it can easily cause bacteria to invade the infection, causing complications that are even life-threatening. Among them, the type and size of the wound, the nutritional status of the injured person, the age, the presence of other diseases and the use of drugs, etc., all affect the process and time of wound healing. In order to accelerate wound healing and reduce the chance of infection, the healing process is usually covered with a suitable dressing at the wound. Existing dressing products, from handy, simple repair products such as repair masks, ok ends, gauze, sterilized bandages, to the use of surgical materials, bone supports, usually coated on the fabric Medical effect drugs. The fabric is mainly composed of materials with auxiliary fixation, venting and antibacterial effects, and usually only provides the function of covering the wound and reducing the external staining of external bacteria. As for wound repair, tissue growth and other effects, it is mainly dependent on the body's own repair mechanism. Therefore, 'how to improve the functionality of the fabric, so that it not only has the effect of the existing medical 3 M392663 __ (four) fixed and sputum, but also can provide further promotion of tissue growth and accelerate wound healing, to become a clinical and cosmetic medicine. Restoration research (4) The subject is also a key technology worthy of in-depth study. [New content] Therefore, the present invention aims to provide a fabric which can promote tissue growth and has a fixed coating and an accelerated scar healing function. Thus, the novel fabric which promotes tissue growth comprises a first fibrous layer 'and a second fibrous layer bonded to the first fibrous layer. The first fiber layer comprises a plurality of first-wires that are laid-up in a first direction and joined into a sheet, and the first-wires are made of fibers selected from the group consisting of: a rayon, and a combination of the materials. The second wire is laid on the first _line # in the first edge-second direction, and the wires are respectively drawn by the biopolymer (four) The formed bio-fiber; gas-forming, the bio-polymer colloid comprises a chitosan derivative. The utility model has the beneficial effects that: by the first and second wires, the first and second fiber layers are further combined into a sheet-like design, so that the fabric still has auxiliary fixing and ventilation. The function of use = the ability to promote cell activation and force 1 and: growth through the second: fiber (4) second wire, so that the present invention has practical value for further application of the application of the fourth (four), Meigu medicine and cell culture. . Progressively, the present invention also provides an alternative type of fabric that promotes tissue growth, including a plurality of first-wires, and a plurality of second wires that are interwoven with the first materials to form a sheet-like cloth structure. The wires are made along the fibers of a first group: cotton, a combination of materials. Directionally disposed, and is selected from the group consisting of lower wire, hemp, rayon, and the second wire is interwoven with the first wire in a second direction not parallel to the first direction to form a sheet a cloth structure, and the second wires are respectively biofibers formed by a biopolymer colloid, and the biopolymer colloid comprises a chitosan derivative. The beneficial effects of the present invention are that the fabric has a function of assisting fixation and ventilation by the sheet-like cloth structure formed by the interweaving of the first 'second wires', and the second wire is promoted. The effect of cell activation and accelerated tissue growth, thereby also enabling the present invention to have practical value for further application in clinical medicine, aesthetic medicine and cell culture. The above and other technical contents, features and effects of the present invention will be apparent from the following detailed description of the preferred embodiments. Referring to Figures 1 and 2', a preferred embodiment of the fabric 2 of the present invention which promotes tissue growth comprises - a first fiber comprising a second fibrous layer 4 bonded to the first fibrous layer. The first fiber layer 3 includes a plurality of first wires 31 laminated in a first direction and laminated into a sheet, and the first wires 31 are made of a rayon selected from the group M392663, and the material group. Made of fiber: a combination of cotton, silk and hemp. The second fiber layer 4 is bonded to the first fiber layer 3, and includes a plurality of strips laid on the first wire in a direction of two 31 f-^^ parallel to the first direction. The wire 41, the biofiber formed by the second wire polymer colloid extraction: the carcass comprises a chitosan derivative. In the embodiment, the first wire 31 and the second wire Ο are formed into a sheet type cloth structure by a manufacturing technique of the existing nonwoven fabric. Wherein, the biofiber 411 of the second wire 41 is preferably made into a hollow fiber having a heterogeneous multi-faceted structure, and the fiber structure design is useful for providing nutrient transport required for fine space and tissue growth. It can enhance the use effect of the fabric 2. In this embodiment, the chitosan derivative is an ionic polymer of chitosan, and the biofiber 411 of the second strand is made of chitosan and polyglutamic acid. The mixed solution is made into a hollow fiber having a profiled poly-folded section through a spinning process. ^ In the eighth, Chitosan is a new material for biotechnology in recent years. It has good biocompatibility, good antibacterial property, biodegradability and non-toxicity, and it is simple to manufacture and inexpensive. The advantages of producing raw materials are not set. In an acidic environment, the amino group of chitosan can be protonated' and thus has a positive charge. Therefore, chitosan is a natural polymer that can be positively charged. Furthermore, since the amino group in the chitosan structure has a ruthenium ', the chitosan is reacted by a crosslinking agent and further molded into a specific type of structure, whereby it can be produced into a specific structure. M392663 can further increase its application range and practical value. Polyglutamic acid (7-PGA) is a natural biodegradable material that is currently attracting attention. Its existence in the natto food has a history of more than a thousand years. Its material itself is safe and non-toxic, and it can be used with organisms. The body is fully compatible and biodegradable. 7-PGA is bio-decomposed and then becomes glutamic acid, which is still an important nutrient. Since g-PGA contains many COOH groups and can exhibit a variety of conformational states, it has both chemical and biological versatility. For example, g-PGA can chelate with a variety of heavy metal ions in a neutral solution and produce a sink. g-PGA also has the ability to bind strongly to a variety of physiologically functional proteins. In addition, g-PGA It also has a function of binding to calcium ions and magnesium ions to form a coordinated iron ion structure (Coordinated ionic complex). Therefore, g-PGA has a good health care function. In addition, g-PGA's extra strong hydrophilic water retention capacity and the function of forming dislocation salt ions, as well as linear structure, make it effective in promoting calcium absorption, bone growth and other health physiology. And the value of nutritional functions. Colloidal spinning, also known as chemical fiber forming, is a process in the manufacture of chemical fibers. The general practice is to form a chemical fiber by forming a polymer material into a colloidal solution or melting it into a melt, and then extruding the pores of the spinneret. By combining high-antimicrobial, biocompatible, biodegradable, and non-toxic chitosan, it combines high biocompatibility, high moisturizing power, and protein, calcium, and magnesium ions. Polyurethane with the advantages of the ability, and the ionic polymer colloidal solution of chitosan and polyglutamic acid is made into a hollow fiber with a multi-pleated cross section as the biological 7 fiber in the spinning process, and Stepping the biofibers 4ii into the first wires 41' and then combining the first wires η to form a sheet type fabric, the material properties of the second wires 41 can be used to reach the activated cells and Promote the effect of tissue growth, and #敷织# 2 is applied to the wound site, which effectively enhances the repair effect of the site. Thereby, the effect produced by the material components of the second wire 41 (four) and the first and second wires 31, 41 can be combined into the structure of the cloth body through the existing nonwoven fabric process to make the fabric capable of promoting tissue growth. 2, can be further made into a product selected from the group consisting of a bone tissue stent coating material, a clinical medical dressing, a cosmetic medical body repairing membrane, a cosmetic medical mask, and a cell culture substrate. And has a wide range of applications. Referring to Figures 3 and 4, a second preferred embodiment of the fabric 5 for promoting tissue growth is disclosed. The fabric 5 includes a plurality of first wires 51, and a plurality of strips are interwoven with the first wires 51. The second wire 52 is bonded into a sheet-like cloth structure. The first wires 51 are disposed along a first direction X and are made of fibers selected from the group consisting of cotton, silk, hemp, rayon, and combinations of such materials. The second wires 52 are interlaced with the first wires 51 in a second direction Y that is not parallel to the first direction X to form a sheet-like cloth structure, and the second wires 52 are respectively The biopolymer colloid is formed by drawing a biofiber 521 comprising a chitosan derivative. In this embodiment, the chitosan derivative is also an ionic polymer of chitosan and polyglutamic acid. The biofiber forming the wire 52 is also a hollow fiber type having a profiled cross-sectional structure. Here, the fabric 5 is made using the existing two-weft weaving technique. And the weave in which the first and second wires 51, 52 are combined is not limited. The warp and weft textile process used in this embodiment is mainly made up of a fiber selected from the group consisting of 'V, 'thorn' rayon or other existing materials, _ ^41.» ~ . The method of setting the longitude (or latitude) of a textile device (not shown) to: the second wire 52 further supporting the derivative of the 4 chitosan by the colloidal spinning technique is disposed on the textile device. Latitude (or longitude) ~ Next, the fabric 5 which promotes tissue growth of the present embodiment can be obtained by the textile process of the first wire 51 and the second wire 52. The fabric 2 produced in an interwoven manner can also be further produced by the function of producing the cells and promoting the growth and repair of the tissue via the material properties of the second wires - a product selected from the group consisting of: bone tissue The covering material of the stent, the clinical medical dressing, the body repairing membrane of the beauty medicine, the mask of the US medicine and the cell culture substrate. It should be noted that the specific manufacture of the bio-fibers 4 ιι, 52 ι of the second wires 41, 52 used in the first and second preferred embodiments adds a chitosan lg to 10_ In pure water, adjust to pH 4 with acetic acid, and use a magnetizer to mix and dissolve. Take % polyglycolic acid and add it to _ml pure water, and use a magnet mixer to give up the dissolution' and A few T-glycan aqueous solutions are respectively dropped into a human (iv) aqueous solution of aminic acid, and the two solutions are mixed to form an interface reaction, which is then drawn into fibers, and then, after M392663 is subjected to alcohol curing, oven drying, winding, and the like, Ion-crosslinked fibers of chitosan-polyglutamic acid can be obtained. Referring to Figures 3 and 4, the fibers are used as the biofiber 4 in the first and second preferred embodiments, 521, and the bio-fibers 411, 521 can be set via tanning technology. The bundles 'are formed into the second wires 41' 52, respectively. In summary, the present invention can promote the growth of fabrics 2, 5, which can achieve the following effects and advantages - so that the purpose of the present invention can be achieved: - according to the first and second preferred embodiments, the creatures The second wires 41, 52 formed by the fibers 411, 521 can provide not only the appropriate environment for cell culture by chitosan and polyglutamic acid, but also the hollow of the ion-crosslinked fibers of chitosan-polyglycolic acid. With the profiled pleat section structure, it can provide space for cell retention and nutrient transport required for tissue growth. Accordingly, the fabrics 2, 5 which promote tissue growth of the first and second preferred embodiments can effectively promote the growth of cells and tissues. Therefore, the fabric 2, 5 which can promote tissue growth can be applied to clinical medical wound dressings, aggregate culture materials, cell culture materials, bone stent coatings, or other surgical aspects related to cell repair and growth. Applications, as well as cosmetic masks for repairing facial masks, or other body parts, such as hand masks, foot masks, etc. 2. The first strands 51, 51 and the second strands 41, 52 of the fabrics 2, 5 which promote tissue growth are all made of components which can be decomposed, and therefore are further made of the fabrics 2, 5 After the product is used, there is no problem that it cannot be decomposed and it is easy to become an environmental burden. Therefore, the fabric 2 and the product have the effect of meeting environmental protection requirements. However, the above is only a preferred embodiment of the present invention. When 10 M392663 b is used to limit the implementation of the novel implementation, that is, the simplicity of the new patent application scope and the new description content. The effect changes and (4) are still within the scope of this new patent. [Simple diagram of the diagram] Figure! Is a partial perspective view illustrating a first preferred embodiment of the fabric of the present invention which promotes tissue growth;

圖2是一剖視示意圖,說明該第—較佳實施例的多數 個第二線材广別由具有異型多摺斷面的中空纖維所形成; 圖3疋一局部立體示意圖,說明太 e Aβ本新型可促進組織生 長的織物的一苐二較佳實施例;及 圖4是一剖視示意圖,說明該第 平乂佳貫施例的多齡 個第二線材分別由具有異型多摺斷面 夕數 τ二纖維所形成。 M392663 【主要元件符號說明】 2 ..........織物 3 ..........第一纖維層 31.........第一線材 4 ..........第二纖維層 41.........第二線材 411.......生物纖維 5 ..........織物 51 .........第一線材 52 .........第二線材 521 .......生物纖維 X..........第一方向 Y..........第二方向 12Figure 2 is a cross-sectional view showing that a plurality of second wires of the first preferred embodiment are formed by hollow fibers having a profiled multi-folded cross section; Figure 3 is a partial perspective view showing a too e Aβ A preferred embodiment of a novel fabric for promoting tissue growth; and FIG. 4 is a cross-sectional view showing that the second wire of the second embodiment of the first embodiment has a profiled polysection The number τ is formed by two fibers. M392663 [Description of main component symbols] 2 ..........fabric 3 ..........first fiber layer 31.........first wire 4 .. ........the second fiber layer 41...the second wire 411.......the biofiber 5 ..........fabric 51.. .......the first wire 52 ....the second wire 521 .......the bio-fiber X..........the first direction Y.. ........second direction 12

Claims (1)

M392663 六、申請專利範圍: 1. 一種可促進組織生長的織物,包含: 一第一纖維層,包括多數條沿-第-方向相舖疊結 合成片的第-線材,且該等第'線材是由—選自: 組中的纖維所製成:棉、絲、麻 '人造纖維,及所 料的組合;及 & 一第二纖維層,是結合在該第一纖維層上,包括多 數條沿一第二方向舖疊在該等第一線材上的第二線材, 該等第二線材分別是由一生物高分子膠體抽製形成的生 物纖維所製成,該生物高分子膠體包含—幾丁聚醋衍生 物。 2. 依據申請專利範圍帛!項所述之可促進組織生長的織物 ’其中’言亥幾丁聚糖衍生才勿是幾了⑽與聚楚胺酸之離 子聚合物。 3. 依射請專利範圍第2項所述之可促進組織生長的織物 ’其中’形成該第二線材的生物纖維是具有異型多褶斷 面結構的中空纖維。 4. 依據中料職圍第丨項所述之可促進組織生長的織物 ,其中,s亥第一方向與該第二方向為相平行。 5·依射請專利範圍第丨.項至第3項中任__項所述之可促 進組織生長的織物,是進一步製成一選自下列群組中的 產品:骨組織支架的包覆材料、臨床醫學之敷料、美容 醫學之身體修復膜片、美容醫學之面膜及細胞培養基材 13 M392663 —方向設置,且是由一 棉 '絲、麻、人造纖維 一種可促進組織生長的織物,包含: 多數條第一線材,是沿一第—: 選自下列群組中的纖維所製成:棉 及所述材料的組合;及 多數條第二線材,是沿一 一不平行於該第一方向的第 =方向與該等第一線材相交織形成片狀布體結構,且該 等第二線材分別是由一生物高分子膠體抽製形成的生物 ,且該M392663 VI. Scope of Application: 1. A fabric capable of promoting tissue growth, comprising: a first fiber layer comprising a plurality of first-wires laminated in a first-to-first direction and combined into a sheet, and the first wire Made from: fibers selected from the group: cotton, silk, hemp 'synthetic fibers, and combinations of materials; and & a second fibrous layer bonded to the first fibrous layer, including the majority a second wire which is laid on the first wire along a second direction, wherein the second wires are respectively made of biofiber formed by a biopolymer colloid, and the biopolymer colloid comprises- Chitin polyacetate derivatives. 2. According to the scope of application for patents! The fabric described in the section which promotes tissue growth is not an ionic polymer of (10) with poly-chrysolic acid. 3. According to the invention, the fabric which promotes tissue growth as described in the second item of the patent scope, wherein the biofiber forming the second wire is a hollow fiber having a profiled multi-pleated sectional structure. 4. The fabric which promotes tissue growth as described in the middle item of the middle material, wherein the first direction of the shai is parallel to the second direction. 5. According to the scope of the patent, the fabrics which promote tissue growth as described in Item __ to Item 3 are further made into a product selected from the group consisting of: bone tissue stent coating Materials, clinical medical dressings, body repair masks for cosmetic medicine, facial masks for beauty medicine and cell culture materials 13 M392663 - directional setting, and is a fabric made of cotton, silk, hemp, rayon, which promotes tissue growth. The method comprises: a plurality of first wires, which are made along a fiber selected from the group consisting of cotton and a combination of the materials; and a plurality of second wires which are not parallel to the first a first direction of the first direction is interlaced with the first wires to form a sheet-like cloth structure, and the second wires are respectively formed by a biopolymer colloid, and the 7. 依據申請專利範圍第6項所述之可促進組織生長的織物 ,其中,該幾丁聚醣衍生物是幾丁聚醣與聚麩胺酸之離 子聚合物。 8. 依據申請專利範圍第6項所述之可促進組織生長的織物 其中’形成該第二線材的生物纖維是具有異型多權斷 面結構的中空纖維。 9. 依據申請專利範圍第6項至第8項中任一項所述之可促 進組織生長的織物,是進一步製成一選自下列群組中的 產品:骨組織支架的包覆材料、臨床醫學之敷料、美容 醫學之身體修復膜片、美容醫學之面膜及細胞培養基材 147. The fabric for promoting tissue growth according to claim 6, wherein the chitosan derivative is an ionomer of chitosan and polyglutamic acid. 8. A fabric which promotes tissue growth according to claim 6 of the patent application wherein the biofiber forming the second wire is a hollow fiber having a heterogeneous multi-weighted structure. 9. The fabric for promoting tissue growth according to any one of claims 6 to 8, which is further prepared as a product selected from the group consisting of a bone tissue scaffold coating material and a clinical Medical dressings, body repair masks for beauty medicine, facial masks for beauty medicine and cell culture materials 14
TW99212319U 2010-06-29 2010-06-29 Fabric for promoting tissue growth TWM392663U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99212319U TWM392663U (en) 2010-06-29 2010-06-29 Fabric for promoting tissue growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99212319U TWM392663U (en) 2010-06-29 2010-06-29 Fabric for promoting tissue growth

Publications (1)

Publication Number Publication Date
TWM392663U true TWM392663U (en) 2010-11-21

Family

ID=50605476

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99212319U TWM392663U (en) 2010-06-29 2010-06-29 Fabric for promoting tissue growth

Country Status (1)

Country Link
TW (1) TWM392663U (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI424860B (en) * 2011-05-31 2014-02-01 Far Eastern New Century Corp High water absorption antibacterial dressing
CN114949353A (en) * 2022-01-24 2022-08-30 东华大学 Biological function differentiated adaptation musculoskeletal system prosthesis and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI424860B (en) * 2011-05-31 2014-02-01 Far Eastern New Century Corp High water absorption antibacterial dressing
CN114949353A (en) * 2022-01-24 2022-08-30 东华大学 Biological function differentiated adaptation musculoskeletal system prosthesis and preparation method thereof
CN114949353B (en) * 2022-01-24 2023-05-30 东华大学 Biological function differentiated adaptive musculoskeletal system prosthesis and preparation method thereof

Similar Documents

Publication Publication Date Title
Morris et al. Medical textiles
CN100400019C (en) Emergency wound dressing and its preparation method
CN103463668B (en) A kind of preparation method of silk fibroin-calcium alginate biological wound porous dressing
CN105727346B (en) A kind of hemostatic textile and the preparation method and application thereof
CN101703794B (en) Controlled degradable surgical suture thread and fabricating method thereof
CN103550817B (en) A kind of Bacterial cellulose/shitosan composite sponge dressing and preparation method thereof
Shirvan et al. Medical textiles
CN105126151B (en) A kind of collagen dressing patch and its preparation method and application
CN103768650A (en) Wound regenerating and repairing bandage and manufacture method thereof
CN106110369B (en) A kind of medical composite type hyaluronic acid dressing and preparation method thereof
CN104947320B (en) A kind of bio-medical energy-saving and temperature-regulating tunica fibrosa and preparation method thereof
Liu et al. Research progress on the use of micro/nano carbon materials for antibacterial dressings
CN1775302A (en) Chitose-gelatine sponge wound dressing preparing method
CN201533923U (en) Controllably degraded surgery suture
CN105411746B (en) A kind of nanometer multilayer compound hemostatic plaster and the preparation method and application thereof
CN113197705B (en) Barbed silk suture line and preparation method thereof
TWM392663U (en) Fabric for promoting tissue growth
CN103877609A (en) Wound-surface-dressing waterproof fabric production method
Reddy Innovative and multidirectional applications of natural fibre, silk-a review
CN110882409B (en) Composite hydrophilic fiber dressing and preparation method thereof
CN107670093A (en) A kind of anti-sticky type antibacterial medical bandage
CN110420344B (en) Wound dressing and preparation method and application thereof
CN109512577B (en) Healing-promoting biological environment-friendly medical dressing and manufacturing method thereof
CN105343923A (en) Medical dressing material and preparation method thereof
CN109966540A (en) A kind of preparation method and application of nano-chitosan compound calcium alginate medical dressing

Legal Events

Date Code Title Description
MM4K Annulment or lapse of a utility model due to non-payment of fees